{"id":1074,"date":"2018-05-29T00:00:16","date_gmt":"2018-05-29T00:00:16","guid":{"rendered":"https:\/\/webdev2.a2x.co.za\/?p=1074"},"modified":"2024-07-15T17:23:10","modified_gmt":"2024-07-15T15:23:10","slug":"ascendis-health-secondary-lists-on-a2x","status":"publish","type":"post","link":"https:\/\/www.a2x.co.za\/?p=1074","title":{"rendered":"Ascendis Health secondary lists on A2X"},"content":{"rendered":"<p><strong>Ascendis Health CEO, Thomas Thomsen<\/strong>\u00a0said,\u00a0<em>\u201cWe are pleased to complement our primary listing on the JSE with the secondary listing on A2X. We see the secondary listing as an opportunity to attract potential new investors through the lower-cost trading structure of A2X and broaden our shareholder base. There is no cost to the secondary listing or any additional regulatory compliance.\u201d<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ascendis Health CEO, Thomas Thomsen\u00a0said,\u00a0\u201cWe are pleased to complement our primary listing on the JSE with the secondary listing on A2X. We see the secondary listing as an opportunity to attract potential new investors through the lower-cost trading structure of A2X and broaden our shareholder base. There is no cost to the secondary listing or [&#8230;]\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[9,7,6,8],"tags":[],"class_list":["post-1074","post","type-post","status-publish","format-standard","hentry","category-announcements","category-listings","category-listingtimeline","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ascendis Health secondary lists on A2X - A2X Markets<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.a2x.co.za\/?p=1074\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ascendis Health secondary lists on A2X - A2X Markets\" \/>\n<meta property=\"og:description\" content=\"Ascendis Health CEO, Thomas Thomsen\u00a0said,\u00a0\u201cWe are pleased to complement our primary listing on the JSE with the secondary listing on A2X. We see the secondary listing as an opportunity to attract potential new investors through the lower-cost trading structure of A2X and broaden our shareholder base. There is no cost to the secondary listing or [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.a2x.co.za\/?p=1074\" \/>\n<meta property=\"og:site_name\" content=\"A2X Markets\" \/>\n<meta property=\"article:published_time\" content=\"2018-05-29T00:00:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-15T15:23:10+00:00\" \/>\n<meta name=\"author\" content=\"Daniel van Loggerenberg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@A2X_Markets\" \/>\n<meta name=\"twitter:site\" content=\"@A2X_Markets\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Daniel van Loggerenberg\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/?p=1074#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/?p=1074\"},\"author\":{\"name\":\"Daniel van Loggerenberg\",\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/#\\\/schema\\\/person\\\/39c56d98291cff927acba2f1d4ee91dc\"},\"headline\":\"Ascendis Health secondary lists on A2X\",\"datePublished\":\"2018-05-29T00:00:16+00:00\",\"dateModified\":\"2024-07-15T15:23:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/?p=1074\"},\"wordCount\":70,\"publisher\":{\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/#organization\"},\"articleSection\":[\"Announcements\",\"Listings\",\"listingtimeline\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/?p=1074\",\"url\":\"https:\\\/\\\/www.a2x.co.za\\\/?p=1074\",\"name\":\"Ascendis Health secondary lists on A2X - A2X Markets\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/#website\"},\"datePublished\":\"2018-05-29T00:00:16+00:00\",\"dateModified\":\"2024-07-15T15:23:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/?p=1074#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.a2x.co.za\\\/?p=1074\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/?p=1074#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.a2x.co.za\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ascendis Health secondary lists on A2X\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/#website\",\"url\":\"https:\\\/\\\/www.a2x.co.za\\\/\",\"name\":\"A2X Markets\",\"description\":\"A2X Markets is an exchange licensed in terms of the Financial Markets Act, 2012\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.a2x.co.za\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/#organization\",\"name\":\"A2X Markets\",\"url\":\"https:\\\/\\\/www.a2x.co.za\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.a2x.co.za\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/logo-dark.png\",\"contentUrl\":\"https:\\\/\\\/www.a2x.co.za\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/logo-dark.png\",\"width\":212,\"height\":88,\"caption\":\"A2X Markets\"},\"image\":{\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/A2X_Markets\",\"https:\\\/\\\/za.linkedin.com\\\/company\\\/a2x-markets\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.a2x.co.za\\\/#\\\/schema\\\/person\\\/39c56d98291cff927acba2f1d4ee91dc\",\"name\":\"Daniel van Loggerenberg\",\"url\":\"https:\\\/\\\/www.a2x.co.za\\\/?author=2\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ascendis Health secondary lists on A2X - A2X Markets","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.a2x.co.za\/?p=1074","og_locale":"en_US","og_type":"article","og_title":"Ascendis Health secondary lists on A2X - A2X Markets","og_description":"Ascendis Health CEO, Thomas Thomsen\u00a0said,\u00a0\u201cWe are pleased to complement our primary listing on the JSE with the secondary listing on A2X. We see the secondary listing as an opportunity to attract potential new investors through the lower-cost trading structure of A2X and broaden our shareholder base. There is no cost to the secondary listing or [...]","og_url":"https:\/\/www.a2x.co.za\/?p=1074","og_site_name":"A2X Markets","article_published_time":"2018-05-29T00:00:16+00:00","article_modified_time":"2024-07-15T15:23:10+00:00","author":"Daniel van Loggerenberg","twitter_card":"summary_large_image","twitter_creator":"@A2X_Markets","twitter_site":"@A2X_Markets","twitter_misc":{"Written by":"Daniel van Loggerenberg"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.a2x.co.za\/?p=1074#article","isPartOf":{"@id":"https:\/\/www.a2x.co.za\/?p=1074"},"author":{"name":"Daniel van Loggerenberg","@id":"https:\/\/www.a2x.co.za\/#\/schema\/person\/39c56d98291cff927acba2f1d4ee91dc"},"headline":"Ascendis Health secondary lists on A2X","datePublished":"2018-05-29T00:00:16+00:00","dateModified":"2024-07-15T15:23:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.a2x.co.za\/?p=1074"},"wordCount":70,"publisher":{"@id":"https:\/\/www.a2x.co.za\/#organization"},"articleSection":["Announcements","Listings","listingtimeline","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.a2x.co.za\/?p=1074","url":"https:\/\/www.a2x.co.za\/?p=1074","name":"Ascendis Health secondary lists on A2X - A2X Markets","isPartOf":{"@id":"https:\/\/www.a2x.co.za\/#website"},"datePublished":"2018-05-29T00:00:16+00:00","dateModified":"2024-07-15T15:23:10+00:00","breadcrumb":{"@id":"https:\/\/www.a2x.co.za\/?p=1074#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.a2x.co.za\/?p=1074"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.a2x.co.za\/?p=1074#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.a2x.co.za\/"},{"@type":"ListItem","position":2,"name":"Ascendis Health secondary lists on A2X"}]},{"@type":"WebSite","@id":"https:\/\/www.a2x.co.za\/#website","url":"https:\/\/www.a2x.co.za\/","name":"A2X Markets","description":"A2X Markets is an exchange licensed in terms of the Financial Markets Act, 2012","publisher":{"@id":"https:\/\/www.a2x.co.za\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.a2x.co.za\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.a2x.co.za\/#organization","name":"A2X Markets","url":"https:\/\/www.a2x.co.za\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.a2x.co.za\/#\/schema\/logo\/image\/","url":"https:\/\/www.a2x.co.za\/wp-content\/uploads\/2023\/11\/logo-dark.png","contentUrl":"https:\/\/www.a2x.co.za\/wp-content\/uploads\/2023\/11\/logo-dark.png","width":212,"height":88,"caption":"A2X Markets"},"image":{"@id":"https:\/\/www.a2x.co.za\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/A2X_Markets","https:\/\/za.linkedin.com\/company\/a2x-markets"]},{"@type":"Person","@id":"https:\/\/www.a2x.co.za\/#\/schema\/person\/39c56d98291cff927acba2f1d4ee91dc","name":"Daniel van Loggerenberg","url":"https:\/\/www.a2x.co.za\/?author=2"}]}},"_links":{"self":[{"href":"https:\/\/www.a2x.co.za\/index.php?rest_route=\/wp\/v2\/posts\/1074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.a2x.co.za\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.a2x.co.za\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.a2x.co.za\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.a2x.co.za\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1074"}],"version-history":[{"count":1,"href":"https:\/\/www.a2x.co.za\/index.php?rest_route=\/wp\/v2\/posts\/1074\/revisions"}],"predecessor-version":[{"id":1075,"href":"https:\/\/www.a2x.co.za\/index.php?rest_route=\/wp\/v2\/posts\/1074\/revisions\/1075"}],"wp:attachment":[{"href":"https:\/\/www.a2x.co.za\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.a2x.co.za\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.a2x.co.za\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}